Also Known As:
MRD-CLL Panel
The panel helps evaluate minimal residual disease (MRD) in chronic lymphocytic leukemia (CLL) patients. It provides crucial information to help your doctor evaluate and manage related conditions.
Includes 1 Test Parameters
Test Preparation:
No Special Preparation. Informed Consent Required.
Reporting TAT:
24 Hours